This post summarizes a PLOS ONE qualitative study and explains how AI-enabled qualitative research can help teams measure and act on psychological safety during medication conversations. The primary keyword is psychological safety during medication conversations. According to the PLOS ONE study published August 20, 2026, patients described three linked dimensions that shaped safety in medication talks: belonging, learning, and participation, and these dimensions directly affected patients' willingness to ask questions and engage in decisions.
Key Takeaways
Answer: Psychological safety during medication conversations is shaped by feeling heard, getting clear information, and being invited into decisions, and those features predict whether patients will speak up about medication concerns, according to the PLOS ONE study (Aug 20, 2026). PLOS ONE
- The PLOS ONE study published August 20, 2026 interviewed 21 participants who had taken at least one medication for three months or more (n = 21), with interviews conducted May–August 2024.
- In the PLOS ONE sample 19 participants were aged 40 or older (n = 19) and 14 identified as White (n = 14), showing the study context and limits when generalising to younger or more diverse populations.
- The PLOS ONE authors used the Patient Psychological Safety (PPS) framework and reported three constructs: Patient Belonging, Patient Learning, and Patient Participating, each of which affected patient openness in medication conversations.
What happened and how it was measured
Answer: The research team conducted a secondary qualitative analysis of interviews and focus groups to explore patient experiences of psychological safety in medication-related encounters, as reported in PLOS ONE on August 20, 2026.
According to the PLOS ONE study published August 20, 2026, data came from semi-structured interviews and focus groups conducted between May 1 and August 31, 2024, with sessions audio-recorded and transcribed for analysis.
The PLOS ONE authors used the Patient Psychological Safety (PPS) framework in a deductive matrix aligned to three domains: Patient Belonging (feeling accepted), Patient Learning (feeling encouraged to ask questions), and Patient Participating (feeling safe to share opinions).
Key findings in the PLOS ONE analysis included that respectful, empathetic interactions supported belonging, clear contextualized information supported learning, and explicit invitations to decide supported participation; conversely, dismissal, stigma, and time-constrained encounters reduced psychological safety.
Direct participant voice from the PLOS ONE study illustrates the themes: "I try to treat providers respectfully and behave in an intelligent way with them. And they treat me as an equal" [P10], and "I want to be a part of the decisions that are made about my care and my treatment including the medications I’m prescribed" [P03].
Findings Snapshot
| Date | Metric | Value | Implication (from PLOS ONE) |
|---|---|---|---|
| Aug 20, 2026 | Publication | PLOS ONE | Peer-reviewed qualitative study reporting psychological safety constructs for medication conversations |
| May–Aug 2024 | Data collection period | Interviews and focus groups conducted May 1–Aug 31, 2024 | Findings reflect patient experiences captured during those months |
| 2024 (sample) | Participants | n = 21 | Small qualitative sample, rich interviews; limits transferability noted in PLOS ONE |
| 2024 (sample) | Age distribution | n = 19 aged ≥40 | PLOS ONE notes limited representation of younger adults |
| 2024 (sample) | Race | n = 14 White | PLOS ONE highlights need to study more diverse social locations |
Implications for clinical researchers and quality teams
Answer: Clinical researchers should measure belonging, learning, and participation when studying medication communication because those domains predict patients' willingness to disclose concerns, as shown in PLOS ONE (Aug 20, 2026).
Researchers designing studies on medication conversations should adopt a framework such as the Patient Psychological Safety (PPS) framework, which the PLOS ONE authors applied to structure analysis and interpret patient narratives.
The PLOS ONE study published August 20, 2026 highlights common barriers researchers should measure: perceived dismissal, stigma, information overload, and structural constraints like short appointment times.
Quality teams and evaluators should pair qualitative interview data with patient-reported experience measures, as the PLOS ONE authors note this mixed approach can reveal actionable gaps in communication and decision-making.
For policy-focused work, the PLOS ONE authors point to system-level levers (appointment length, continuity, training) as priorities for future interventions to improve psychological safety.
How Evidano Helps
Definition and first step
Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.
Problem: Slow manual synthesis of psychological-safety interviews (PLOS ONE required transcript review and matrix coding). Solution: Use Evidano to auto-ingest transcripts, apply consistent coding matrices, and produce theme-frequency tables in minutes rather than weeks.
Problem: Missing context when aggregating quotes across participant subgroups (PLOS ONE noted limits in demographic diversity). Solution: Evidano supports cross-segment analyses so teams can filter and compare themes by age, race, gender, or other tags.
Transcription and PII-safe processing
Problem: Manual transcription and PII redaction slow secondary qualitative analyses like the PLOS ONE team conducted. Solution: Evidano offers transcription with custom dictionaries and PII redaction to produce research-ready transcripts quickly, reducing hands-on prep time. See Speech-to-Text for details.
Framework-driven coding
Problem: Applying a framework such as PPS requires consistent matrix coding across transcripts, as the PLOS ONE authors used an Excel matrix. Solution: Evidano lets teams import a codebook aligned to frameworks (for example, Patient Belonging, Learning, Participating), auto-code candidate passages, and surface representative quotes for each construct.
Feature link: Learn more on Evidano features.
From findings to action
Problem: Translating qualitative themes into operational changes is time consuming. Solution: Evidano generates exportable tables, visualizations, and segment comparisons to inform training, measurement, and policy decisions faster.
FAQ: psychological safety during medication conversations
What is psychological safety during medication conversations?
Answer: Psychological safety during medication conversations means patients feel respected, able to ask questions, and safe to raise concerns without fear of being dismissed, as defined by the Patient Psychological Safety (PPS) framework used in the PLOS ONE study (Aug 20, 2026).
Supporting detail: The PLOS ONE authors analysed interview data into three PPS domains: belonging, learning, and participating, each shaping whether patients speak up about medication issues.
Which methods did the PLOS ONE study use to assess psychological safety?
Answer: The PLOS ONE study used semi-structured interviews and focus groups collected May–Aug 2024 and applied a deductive matrix analysis guided by the PPS framework, as described in the PLOS ONE paper (Aug 20, 2026).
Supporting detail: The authors coded transcripts into an Excel data display matrix and used multiple analysts to reach consensus, mirroring common qualitative rigour practices.
How should researchers measure psychological safety in new studies?
Answer: Researchers should combine framework-guided qualitative interviews with structured patient-reported experience measures and clear demographic tagging to assess equity impacts, a recommendation aligned with the PLOS ONE discussion (Aug 20, 2026) and World Health Organization guidance on patient engagement.
Supporting detail: The PLOS ONE authors call for research that examines intersections with race, gender, and disability to identify targeted interventions.
Can AI platforms like Evidano be used ethically for this work?
Answer: Yes, when platforms follow ethics guardrails for consent, de-identification, and secure data handling; the PLOS ONE study itself followed University of Toronto ethics approval and consent procedures (REB #46159) for participant protections.
Supporting detail: Teams should ensure transcripts are de-identified and that analysis only uses data per consent terms; Evidano supports PII redaction and secure processing workflows.
Conclusion & Next Steps
Answer: The PLOS ONE study (published Aug 20, 2026) shows that fostering belonging, learning, and participation can increase patient openness in medication conversations, and researchers and teams can accelerate insight-to-action with AI-enabled qualitative workflows.
If you run qualitative research on medication communication or patient experience, adopt a clear framework such as PPS, collect demographic tags to assess equity, and use AI tools to reduce manual coding time while preserving analytic transparency.
To explore how Evidano can speed transcript processing, framework coding, and cross-segment analysis for your medication-safety projects, Try Evidano for free.
Topics
- psychological safety during medication conversations
- patient psychological safety
- qualitative analysis medication conversations
- AI-enabled qualitative research
Keep reading
- Commentary on NewsImproving Psychological Safety in Medication ConversationsWhat builds patient psychological safety when discussing medications and how AI-enabled qualitative research can help. Insights from a PLOS ONE study plus practical next steps.
- Commentary on NewsAI for Qualitative Analysis of Museum VisitorsAI turns observation notes into insights: qualitative analysis of museum visitors that finds themes, age segments, and exhibit recommendations for UX teams
- Commentary on NewsBoost Exhibit Design: AI Qualitative Analysis for MuseumsUse AI qualitative analysis for museums to convert observational studies into targeted exhibit changes. Learn from PLOS ONE findings and try Evidano to accelerate insight.